Alaco, Inc., et al. Seek FDA Hearing on Withdrawal of New Animal Drug Approvals

Summary

The FDA is proposing to withdraw approval of seven new animal drug applications due to repeated failure to file required annual reports, and is offering NADA holders the opportunity to request a hearing on the proposal.